Movement Alert｜ASYMCHEM Falls 3.02% in Regular Trading, Institutional Reduction and Pre-Holiday Risk Aversion Weigh on Shares

Market Focus10-08

On October 8, ASYMCHEM fell 3.02% in regular trading, trading at HK$160.50 with turnover of HK$69.6041 million.

The decline comes amid continued institutional selling pressure. JPMorgan reduced its long position by 83,200 shares on September 23 at an average price of HK$159.1287 per share, lowering its stake to 8.8%. Schroders PLC also cut 175,800 shares on September 24 at approximately HK$150.23 per share. The consecutive institutional reductions have dampened market sentiment. Although the company's fundamentals remain solid, including an order backlog of US$1.673 billion up 53.77% year-over-year and its chemical macromolecule site passing FDA pre-approval inspection, the combination of pre-holiday risk aversion and foreign capital rebalancing pressure continues to weigh on the stock.

ASYMCHEM is a China-based company providing one-stop pharmaceutical outsourcing services, including small molecule CDMO, chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output, and synthetic biology.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120739490?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 14:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120739490","market":"hk","top_or_hot":-1,"title":"Movement Alert｜ASYMCHEM Falls 3.02% in Regular Trading, Institutional Reduction and Pre-Holiday Risk Aversion Weigh on Shares","media":"Market Focus","content":"<p><p>On October 8, ASYMCHEM fell 3.02% in regular trading, trading at HK$160.50 with turnover of HK$69.6041 million.</p><p>The decline comes amid continued institutional selling pressure. JPMorgan reduced its long position by 83,200 shares on September 23 at an average price of HK$159.1287 per share, lowering its stake to 8.8%. Schroders PLC also cut 175,800 shares on September 24 at approximately HK$150.23 per share. The consecutive institutional reductions have dampened market sentiment. Although the company's fundamentals remain solid, including an order backlog of US$1.673 billion up 53.77% year-over-year and its chemical macromolecule site passing FDA pre-approval inspection, the combination of pre-holiday risk aversion and foreign capital rebalancing pressure continues to weigh on the stock.</p><p>ASYMCHEM is a China-based company providing one-stop pharmaceutical outsourcing services, including small molecule CDMO, chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output, and synthetic biology.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ASYMCHEM Falls 3.02% in Regular Trading, Institutional Reduction and Pre-Holiday Risk Aversion Weigh on Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ASYMCHEM Falls 3.02% in Regular Trading, Institutional Reduction and Pre-Holiday Risk Aversion Weigh on Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-08 14:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 8, ASYMCHEM fell 3.02% in regular trading, trading at HK$160.50 with turnover of HK$69.6041 million.</p><p>The decline comes amid continued institutional selling pressure. JPMorgan reduced its long position by 83,200 shares on September 23 at an average price of HK$159.1287 per share, lowering its stake to 8.8%. Schroders PLC also cut 175,800 shares on September 24 at approximately HK$150.23 per share. The consecutive institutional reductions have dampened market sentiment. Although the company's fundamentals remain solid, including an order backlog of US$1.673 billion up 53.77% year-over-year and its chemical macromolecule site passing FDA pre-approval inspection, the combination of pre-holiday risk aversion and foreign capital rebalancing pressure continues to weigh on the stock.</p><p>ASYMCHEM is a China-based company providing one-stop pharmaceutical outsourcing services, including small molecule CDMO, chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output, and synthetic biology.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06821","symbol_name":"凯莱英","start_time":0,"source_url":"","article_id":"1120739490","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120739490","pubTimestamp":1791441474,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 8, ASYMCHEM fell 3.02% in regular trading, trading at HK$160.50 with turnover of HK$69.6041 million.The decline comes amid continued institutional selling pressure. JPMorgan reduced its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06821":"凯莱英"},"translate_title":"走势提醒|凯莱英常规交易下跌3.02%，机构减持和节前避险情绪打压股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06821":1},"content_text":"On October 8, ASYMCHEM fell 3.02% in regular trading, trading at HK$160.50 with turnover of HK$69.6041 million.The decline comes amid continued institutional selling pressure. JPMorgan reduced its long position by 83,200 shares on September 23 at an average price of HK$159.1287 per share, lowering its stake to 8.8%. Schroders PLC also cut 175,800 shares on September 24 at approximately HK$150.23 per share. The consecutive institutional reductions have dampened market sentiment. Although the company's fundamentals remain solid, including an order backlog of US$1.673 billion up 53.77% year-over-year and its chemical macromolecule site passing FDA pre-approval inspection, the combination of pre-holiday risk aversion and foreign capital rebalancing pressure continues to weigh on the stock.ASYMCHEM is a China-based company providing one-stop pharmaceutical outsourcing services, including small molecule CDMO, chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output, and synthetic biology.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120739490","isCrawlerRequest":true}